Related Experiment Videos
Vigilance systems in the EU and the US: a short comparison
1CellPro Europe, Wezembeek-Oppem, Belgium.
Medical Device Technology
|June 7, 1994
Summary
This article compares medical device vigilance systems in the European Union and United States, detailing required information and reporting timeframes. Differences underscore the need for procedural standardization for global medical device companies.
Area of Science:
- Regulatory Affairs
- Medical Device Safety
Background:
- Medical device vigilance systems are crucial for post-market surveillance.
- Differing regulatory landscapes can complicate compliance for global manufacturers.
Purpose of the Study:
- To compare and contrast medical device vigilance system requirements in the European Union and the United States.
- To identify key differences in data collection and reporting timelines for adverse incidents.
Main Methods:
- Comparative analysis of European Union and United States regulatory guidelines for medical device vigilance.
- Detailed examination of adverse incident reporting requirements, including information types and submission deadlines.
Main Results:
- Significant variations exist in the specific data mandated for collection post-adverse incident.
- Contrasting timeframes for reporting adverse events to regulatory authorities were identified between the two regions.
Conclusions:
- The discrepancies in vigilance procedures necessitate a move towards greater international standardization.
- Harmonization of reporting requirements would reduce compliance burdens for companies operating in both the EU and US markets.